MOSCOW (Sputnik) - Alexander Gintsburg, the director of Russia’s Gamaleya Institute, which developed the first registered COVID-19 vaccine, told Sputnik on Friday that patients show adequate lev
MOSCOW (Sputnik) - Alexander Gintsburg, the director of Russia’s Gamaleya Institute, which developed the first registered COVID-19 vaccine, told Sputnik on Friday that patients show adequate lev
MOSCOW (Sputnik) - Alexander Gintsburg, the director of Russia’s Gamaleya Institute, which developed the first registered COVID-19 vaccine, told Sputnik on Friday that patients show adequate lev
MOSCOW (Sputnik) - Alexander Gintsburg, the director of Russia’s Gamaleya Institute, which developed the first registered COVID-19 vaccine, told Sputnik on Friday that patients show adequate lev
MOSCOW (Sputnik) - Alexander Gintsburg, the director of Russia’s Gamaleya Institute, which developed the first registered COVID-19 vaccine, told Sputnik on Friday that patients show adequate lev
MOSCOW (Sputnik) - The Russian biotechnology company Biocad told Sputnik on Thursday that it would produce the COVID-19 vaccine developed by Russia's Gamaleya research centre and was also set to
MOSCOW (Sputnik) - The Russian biotechnology company Biocad told Sputnik on Thursday that it would produce the COVID-19 vaccine developed by Russia's Gamaleya research centre and was also set to
MOSCOW (Sputnik) - The Russian biotechnology company Biocad told Sputnik on Thursday that it would produce the COVID-19 vaccine developed by Russia's Gamaleya research centre and was also set to
MOSCOW (Sputnik) - The Russian biotechnology company Biocad told Sputnik on Thursday that it would produce the COVID-19 vaccine developed by Russia's Gamaleya research centre and was also set to
MOSCOW (Sputnik) - The Russian biotechnology company Biocad told Sputnik on Thursday that it would produce the COVID-19 vaccine developed by Russia's Gamaleya research centre and was also set to
